Inge Marie Svane National Center for Cancer Immune Therapy, Department of Oncology University Hospital Herlev Biography Publications Institution JoVE Articles Inge Marie Svane has not added a biography. If you are Inge Marie Svane and would like to personalize this page please email our Author Liaison for assistance. Publications Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes Supported by Checkpoint Inhibition Across Multiple Solid Cancer Types Journal for Immunotherapy of Cancer. Oct, 2021 | Pubmed ID: 34607899 Lynch Syndrome-associated Epithelial Ovarian Cancer and Its Immunological Profile Gynecologic Oncology. Sep, 2021 | Pubmed ID: 34275654 Clinical Efficacy of T-cell Therapy After Short-term BRAF-inhibitor Priming in Patients with Checkpoint Inhibitor-resistant Metastatic Melanoma Journal for Immunotherapy of Cancer. 07, 2021 | Pubmed ID: 34210820 Bone Marrow Toxicity and Immune Reconstitution in Melanoma and Non-melanoma Solid Cancer Patients After Non-myeloablative Conditioning with Chemotherapy and Checkpoint Inhibition Cytotherapy. 08, 2021 | Pubmed ID: 33933372 Immune Cell Profiling of Peripheral Blood As Signature for Response During Checkpoint Inhibition Across Cancer Types Frontiers in Oncology. 2021 | Pubmed ID: 33842304 The Capacity of CD4 Vγ9Vδ2 T Cells to Kill Cancer Cells Correlates with Co-expression of CD56 Cytotherapy. 07, 2021 | Pubmed ID: 33785258 The Risk of Cardiac Events in Patients Receiving Immune Checkpoint Inhibitors: a Nationwide Danish Study European Heart Journal. 04, 2021 | Pubmed ID: 33291147 The Metabolic Enzyme Arginase-2 is a Potential Target for Novel Immune Modulatory Vaccines Oncoimmunology. 06, 2020 | Pubmed ID: 32923127 Future Role for Adoptive T-cell Therapy in Checkpoint Inhibitor-resistant Metastatic Melanoma Journal for Immunotherapy of Cancer. 07, 2020 | Pubmed ID: 32747469 Escape from Nonsense-mediated Decay Associates with Anti-tumor Immunogenicity Nature Communications. 07, 2020 | Pubmed ID: 32733040 T-Cell Gene Therapy in Cancer Immunotherapy: Why It Is No Longer Just CARs on The Road Cells. 06, 2020 | Pubmed ID: 32630096 In Vitro 4-1BB Stimulation Promotes Expansion of CD8 Tumor-infiltrating Lymphocytes from Various Sarcoma Subtypes Cancer Immunology, Immunotherapy : CII. Nov, 2020 | Pubmed ID: 32472369 Author Correction: Mutational and Putative Neoantigen Load Predict Clinical Benefit of Adoptive T Cell Therapy in Melanoma Nature Communications. Apr, 2020 | Pubmed ID: 32238805 CTLA-4 Blockade Boosts the Expansion of Tumor-reactive CD8 Tumor-infiltrating Lymphocytes in Ovarian Cancer Scientific Reports. 03, 2020 | Pubmed ID: 32127601 Long-Term Exposure to Inflammation Induces Differential Cytokine Patterns and Apoptosis in Dendritic Cells Frontiers in Immunology. 2019 | Pubmed ID: 31824496 Arginase-1-based Vaccination Against the Tumor Microenvironment: the Identification of an Optimal T-cell Epitope Cancer Immunology, Immunotherapy : CII. Nov, 2019 | Pubmed ID: 31690955 Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma Cancers. Oct, 2019 | Pubmed ID: 31623302 MERTK Acts As a Costimulatory Receptor on Human CD8 T Cells Cancer Immunology Research. Sep, 2019 | Pubmed ID: 31266785 Correction: Tumour-reactive T Cell Subsets in the Microenvironment of Ovarian Cancer British Journal of Cancer. Apr, 2019 | Pubmed ID: 30890776 Collagen Density Regulates the Activity of Tumor-infiltrating T Cells Journal for Immunotherapy of Cancer. 03, 2019 | Pubmed ID: 30867051 Tumour-reactive T Cell Subsets in the Microenvironment of Ovarian Cancer British Journal of Cancer. 02, 2019 | Pubmed ID: 30718808 The Real-world Impact of Modern Treatments on the Survival of Patients with Metastatic Melanoma European Journal of Cancer (Oxford, England : 1990). 02, 2019 | Pubmed ID: 30605822 Spontaneous T-cell Responses Against the Immune Check Point Programmed-death-ligand 1 (PD-L1) in Patients with Chronic Myeloproliferative Neoplasms Correlate with Disease Stage and Clinical Response Oncoimmunology. 2018 | Pubmed ID: 29872567 [Cancer Immunotherapy] Ugeskrift for Laeger. May, 2018 | Pubmed ID: 29804567 Cancer Immunotherapy in Patients with Brain Metastases Cancer Immunology, Immunotherapy : CII. May, 2018 | Pubmed ID: 29520474 Frequent Adaptive Immune Responses Against Arginase-1 Oncoimmunology. 2018 | Pubmed ID: 29399404 The Inhibitory Checkpoint, PD-L2, is a Target for Effector T Cells: Novel Possibilities for Immune Therapy Oncoimmunology. 2018 | Pubmed ID: 29308318 T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma-Implications for Adoptive Cell Therapy Cancer Immunology Research. 02, 2018 | Pubmed ID: 29301752 Checkpoint Inhibitors in Breast Cancer - Current Status Cancer Treatment Reviews. Feb, 2018 | Pubmed ID: 29287242 Mutational and Putative Neoantigen Load Predict Clinical Benefit of Adoptive T Cell Therapy in Melanoma Nature Communications. 11, 2017 | Pubmed ID: 29170503 PD-1 Polyfunctional T Cells Dominate the Periphery After Tumor-Infiltrating Lymphocyte Therapy for Cancer Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Oct, 2017 | Pubmed ID: 28679768 Acquired Immune Resistance Follows Complete Tumor Regression Without Loss of Target Antigens or IFNγ Signaling Cancer Research. 09, 2017 | Pubmed ID: 28655789 Dendritic Cell Vaccination in Combination with Docetaxel for Patients with Metastatic Castration-resistant Prostate Cancer: A Randomized Phase II Study Cytotherapy. 04, 2017 | Pubmed ID: 28215654 Safety, Immune and Clinical Responses in Metastatic Melanoma Patients Vaccinated with a Long Peptide Derived from Indoleamine 2,3-dioxygenase in Combination with Ipilimumab Cytotherapy. 08, 2016 | Pubmed ID: 27378345 Transfection of Tumor-Infiltrating T Cells with MRNA Encoding CXCR2 Methods in Molecular Biology (Clifton, N.J.). 2016 | Pubmed ID: 27236805 Immune Monitoring Using MRNA-Transfected Dendritic Cells Methods in Molecular Biology (Clifton, N.J.). 2016 | Pubmed ID: 27236804 Long-Lasting Complete Responses in Patients with Metastatic Melanoma After Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 08, 2016 | Pubmed ID: 27006492 Tumor-infiltrating Lymphocytes for the Treatment of Metastatic Cancer Molecular Oncology. Dec, 2015 | Pubmed ID: 26578452 Reorienting the Immune System in the Treatment of Cancer by Using Anti-PD-1 and Anti-PD-L1 Antibodies Drug Discovery Today. Sep, 2015 | Pubmed ID: 26189934 Indoleamine 2,3-dioxygenase Vaccination Oncoimmunology. Jan, 2015 | Pubmed ID: 25949864 Tryptophan 2,3-dioxygenase (TDO)-reactive T Cells Differ in Their Functional Characteristics in Health and Cancer Oncoimmunology. Jan, 2015 | Pubmed ID: 25949861 Broadening the Repertoire of Melanoma-associated T-cell Epitopes Cancer Immunology, Immunotherapy : CII. May, 2015 | Pubmed ID: 25854582 Spontaneous Presence of FOXO3-specific T Cells in Cancer Patients Oncoimmunology. 2014 | Pubmed ID: 25960934 The Immune Checkpoint Regulator PD-L1 is a Specific Target for Naturally Occurring CD4 T Cells Oncoimmunology. Apr, 2013 | Pubmed ID: 23734334 Silencing of the Glucocorticoid-induced Leucine Zipper Improves the Immunogenicity of Clinical-grade Dendritic Cells Cytotherapy. Jun, 2013 | Pubmed ID: 23643305 Analysis of Survivin-specific T Cells in Breast Cancer Patients Using Human DCs Engineered with Survivin MRNA Methods in Molecular Biology (Clifton, N.J.). 2013 | Pubmed ID: 23296940 FDG PET Scans As Evaluation of Clinical Response to Dendritic Cell Vaccination in Patients with Malignant Melanoma Cancer Immunology, Immunotherapy : CII. Jan, 2013 | Pubmed ID: 22722450 Characterization of T-cell Responses Against IκBα in Cancer Patients Oncoimmunology. Nov, 2012 | Pubmed ID: 23243592 Dissection of T-cell Antigen Specificity in Human Melanoma Cancer Research. Apr, 2012 | Pubmed ID: 22311675 Generation of Autologous Tumor-specific T Cells for Adoptive Transfer Based on Vaccination, in Vitro Restimulation and CD3/CD28 Dynabead-induced T Cell Expansion Cancer Immunology, Immunotherapy : CII. Aug, 2012 | Pubmed ID: 22237888 Tumor Associated Antigen Specific T-cell Populations Identified in Ex Vivo Expanded TIL Cultures Cellular Immunology. 2012 | Pubmed ID: 22230732 Immunotherapy for Metastatic Colorectal Cancer: Present Status and New Options Scandinavian Journal of Gastroenterology. Mar, 2012 | Pubmed ID: 22214467 Characterization of Ex Vivo Expanded Tumor Infiltrating Lymphocytes from Patients with Malignant Melanoma for Clinical Application Journal of Skin Cancer. 2011 | Pubmed ID: 21773037 Identification of a Cyclin B1-derived CTL Epitope Eliciting Spontaneous Responses in Both Cancer Patients and Healthy Donors Cancer Immunology, Immunotherapy : CII. Feb, 2011 | Pubmed ID: 20981424 High Immunogenic Potential of P53 MRNA-transfected Dendritic Cells in Patients with Primary Breast Cancer Breast Cancer Research and Treatment. Jan, 2011 | Pubmed ID: 20336365 CD8 T-cell Responses Against Cyclin B1 in Breast Cancer Patients with Tumors Overexpressing P53 Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Mar, 2009 | Pubmed ID: 19223507 Studies on MRNA Electroporation of Immature and Mature Dendritic Cells: Effects on Their Immunogenic Potential Molecular Biotechnology. Oct, 2008 | Pubmed ID: 18543130 Sitokin Diferansiye İnsan Primer T Hücrelerinde Mitokondriyal Solunumun Gerçek Zamanlı İzlenmesi Kasper Mølgaard*1, Anne Rahbech*1, Özcan Met1, Inge Marie Svane1, Per thor Straten1,3, Claus Desler2, Marlies J. W. Peeters1 1National Center for Cancer Immune Therapy, Department of Oncology, University Hospital Herlev, 2Department of Cellular and Molecular Medicine, Center for Healthy Aging, University of Copenhagen, 3Department of Immunology and Microbiology, Inflammation and Cancer Group, University of Copenhagen JoVE 62984 Immunology and Infection
Sitokin Diferansiye İnsan Primer T Hücrelerinde Mitokondriyal Solunumun Gerçek Zamanlı İzlenmesi Kasper Mølgaard*1, Anne Rahbech*1, Özcan Met1, Inge Marie Svane1, Per thor Straten1,3, Claus Desler2, Marlies J. W. Peeters1 1National Center for Cancer Immune Therapy, Department of Oncology, University Hospital Herlev, 2Department of Cellular and Molecular Medicine, Center for Healthy Aging, University of Copenhagen, 3Department of Immunology and Microbiology, Inflammation and Cancer Group, University of Copenhagen JoVE 62984 Immunology and Infection
